BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Pol M, Kolla NJ. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies. Psychiatry Res 2021;306:114256. [PMID: 34775294 DOI: 10.1016/j.psychres.2021.114256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Patthy Á, Hanics J, Zachar G, Kovács GG, Harkany T, Alpár A. Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn(+/+) mice. Neuropathol Appl Neurobiol 2023;49:e12887. [PMID: 36716771 DOI: 10.1111/nan.12887] [Reference Citation Analysis]
2 Schiavi S, Manduca A, Carbone E, Buzzelli V, Rava A, Feo A, Ascone F, Morena M, Campolongo P, Hill MN, Trezza V. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats. Neuropsychopharmacology 2022. [PMID: 36114286 DOI: 10.1038/s41386-022-01454-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]